par Fountzilas, George;Karkavelas, George;Kalogera-Fountzila, Anna;Karina, Maria;Ignatiadis, Michail ;Koukoulis, George;Plataniotis, George;Misailidou, Despina;Bobos, Mattheos;Pectasides, Dimitrios;Razis, Evangelia;Karavelis, Antonios;Selviaridis, Panagiotis
Référence Anticancer research, 26, 6C, page (4675-4686)
Publication Publié, 2006
Référence Anticancer research, 26, 6C, page (4675-4686)
Publication Publié, 2006
Article révisé par les pairs
Résumé : | Clinical studies have shown that temozolomide (TMZ) and irinotecan demonstrate activity in high grade astrocytic tumors (HGAT). However, the optimal schedule of administration is unknown. |